Cohance Lifesciences Limited (NSE:COHANCE)

Cohance Lifesciences Financials Overview

Financials in millions INR. Fiscal year is April - March.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue Revenue Growth	21,415	22,686	26,085	10,514	13,403	13,202
Revenue Growth	70.12%	-13.03%	148.11%	-21.56%	1.52%	30.75%
Gross Profit Gross Profit Growth	15,067	16,059	17,920	6,797	7,521	7,461
Operating Income Operating Income Growth	1,244	2,397	6,303	3,544	5,262	5,416
Net Income Net Income Growth	1,062	1,792	4,873	3,003	4,113	4,538
Earnings Per Share EPS Growth	-	4.68	12.68	11.80	16.16	17.83
EPS Growth	-	-63.09%	7.50%	-26.99%	-9.37%	25.27%

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Investments Cash & Investments Growth	3,260	3,260	2,942	8,211	4,837	5,258
Total Debt Total Debt Growth	4,005	4,005	4,859	650.1	703.41	971.27
Net Cash (Debt) Net Cash Growth	-745.1	-745.1	-1,917	7,561	4,134	4,287
Net Cash Growth	-	-	-	82.90%	-3.56%	858.10%
Net Cash Per Share Net Cash Per Share Growth	-	-1.95	-4.99	29.70	16.24	16.84

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Cash Flow Operating Cash Flow Growth	-	3,683	6,734	3,848	4,572	3,300
Capital Expenditures CapEx Growth	-	-2,199	-3,168	-518.8	-2,859	-751.87
Free Cash Flow Free Cash Flow Growth	-	1,484	3,566	3,329	1,713	2,548
Free Cash Flow Growth	-	-58.37%	7.11%	94.35%	-32.78%	-6.21%

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Gross Margin	70.36%	70.79%	68.70%	64.65%	56.11%	56.51%
Operating Margin	5.81%	10.56%	24.16%	33.71%	39.26%	41.02%
Pretax Margin	4.74%	9.13%	24.64%	38.59%	41.76%	50.57%
Profit Margin	4.96%	7.90%	18.68%	28.56%	30.69%	34.37%
FCF Margin	-	6.54%	13.67%	31.66%	12.78%	19.30%

Dividends

Chart

Fiscal Year	FY 2023	FY 2022
Period Ending	Mar 31, 2023	Mar 31, 2022
Dividend Per Share Dividend Per Share Growth	3.000	2.000
Dividend Per Share Growth	50.00%	0%
Dividend Yield	0.64%	0.33%

Valuation

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 22, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	166.74	64.35	60.12	57.40	29.24	34.69
Forward PE	81.80	39.98	63.44	44.40	26.23	30.48
P/FCF Ratio	119.33	77.69	82.18	51.78	70.21	61.79
PS Ratio	8.27	5.08	11.23	16.40	8.97	11.93

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 21, 2026

Data Sources Report a data error